Andre Abdo, MD

Instituto do Cancer do Estado de Sâo Paulo - ICESP
Hematology Department, Hospital das Clínicas, Faculdade de Medicina da USP
Avenida Dr Eneas de Carvalho Aguiar 155, Sao Paulo
Sao Paulo Brazil Papers:
4760 Impact of Treatment Free Remission (TFR) with Nilotinib in 2nd Line for Chronic Myeloid Leukemia on Savings That May Fund All BCR-ABL Tests in the Brazilian Public Healthcare System during and after Nilotinib Treatment